May 7 |
Ocular Therapeutix Inc Reports First Quarter 2024 Earnings
|
May 7 |
Ocular Therapeutix GAAP EPS of -$0.49 misses by $0.29, revenue of $14.77M misses by $0.59M
|
May 7 |
Ocular Therapeutix™ Reports First Quarter 2024 Results
|
May 7 |
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
May 6 |
Ocular Therapeutix Q1 2024 Earnings Preview
|
May 6 |
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
|
May 3 |
Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024
|
May 1 |
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
|
Apr 24 |
2 Small-Cap Growth Stocks With Room to Run
|
Apr 19 |
Baird sees weakness in Ocular shares as "overdone"
|